Skip to main content
. 2016 Jan 27;18:13. doi: 10.1186/s13058-016-0673-9

Fig. 5.

Fig. 5

BTG2 is a clinically relevant modulator of tumor progression. Kaplan-Meier curves were generated to assess correlations between B cell translocation gene 2 (BTG2) expression and patient survival. Top and bottom 25 % of patients were used as cutoffs for grouping. a Low BTG2 expression correlates with decreased overall survival of breast cancer patients (all subtypes). b Low BTG2 expression correlates with decreased metastasis-free survival of breast cancer patients (all subtypes). c Low BTG2 expression correlates with decreased overall survival of triple-negative breast cancer (TNBC) patients. Number of patients and p values are indicated in each panel